Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases GST GST + AAR GST - 2023 (6) TMI AAR This

  • Login
  • Cases Cited
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2023 (6) TMI 488 - AAR - GST


Issues Involved:
1. Whether the supply of medicines and other procedures during treatment of inpatients admitted to hospital is a composite supply.
2. Whether supply of medicines and other procedures to inpatients admitted to hospital for treatment is a composite supply where the principal supply is health care services falling under SAC 999311, which is exempted as per entry at SI. No. 74 of Notification No. 12/2017-Central Tax dated 28-6-2017.

Summary:

Issue 1: Composite Supply of Medicines and Procedures
The applicant, M/s Innovations Medi-research Private Limited, operates a unit named Asian Cancer Hospital providing treatment to cancer patients. The treatment process includes consultancy, dispensing of medicines, and procedures such as chemotherapy. The applicant argued that these activities constitute a composite supply as defined under Section 2(30) of the CGST Act, 2017, which includes two or more taxable supplies naturally bundled and supplied in conjunction with each other in the ordinary course of business. The principal supply in this scenario is health care services, with other supplies being ancillary.

Issue 2: Exemption Under Notification No. 12/2017-Central Tax
The applicant contended that the supply of medicines and procedures to inpatients should be exempt under entry 74(a) of Notification No. 12/2017-CGST Rate dated 28-06-2017, which exempts health care services provided by a clinical establishment. The term "health care services" includes diagnosis, treatment, or care for illness in any recognized system of medicines in India. The applicant's hospital qualifies as a clinical establishment under the said notification.

Findings and Analysis:
1. The treatment of cancer patients by the applicant qualifies as a supply under Section 7(1) of the CGST Act, 2017, and falls under health care services (SAC 999311), which is exempt from GST.
2. The supply of medicines and procedures to inpatients is part of the treatment process and cannot be treated separately. These supplies are naturally bundled and provided in conjunction with the principal supply of health care services.
3. Various judicial pronouncements and circulars, such as Circular No. 27/01/2018-GST and Circular No. 32/06/2018-GST, support the view that supplies made in the course of providing treatment to inpatients are part of a composite supply of health care services and are exempt from GST.

Ruling:
1. The supply of medicines and other procedures during the treatment of inpatients admitted to the hospital is a composite supply.
2. The supply of medicines and other procedures to inpatients admitted to the hospital for treatment is a composite supply where the principal supply is health care services falling under SAC 999311, which is exempted as per entry at SI. No. 74 of Notification No. 12/2017-Central Tax dated 28-6-2017.

 

 

 

 

Quick Updates:Latest Updates